Orgenesis Inc. Contracts & Agreements

Form of Warrant to be issued to Jacob Safier (Filed With SEC on August 26, 2024)

Amended and Restated Promissory Note, dated as of August 23, 2024, by and between Orgenesis Maryland LLC, Jacob Safier and Orgenesis Inc (Filed With SEC on August 26, 2024)

Strategic Partnership Agreement, dated as of August 9, 2024, by and between Orgenesis Inc. and Harley Street Healthcare Group (London) Plc Ltd (Filed With SEC on August 14, 2024)

Asset Purchase Agreement, dated as of July 10, 2024, between Orgenesis Inc. and Broaden Bioscience and Technology Corp (Filed With SEC on July 12, 2024)

Asset Purchase Agreement, dated as of July [12], 2024, among Orgenesis Inc., Theracell Advanced Biotechnology S.A, Theracell Advanced Biotechnology LTD and IDNA Genomics Public... (Filed With SEC on July 12, 2024)

Loan Agreement dated July 3, 2024, by and among the Borrower and Yehuda Nir (Filed With SEC on July 8, 2024)

Orgenesis Inc. 2017 Equity Incentive Plan, as amended (Filed With SEC on June 27, 2024)

Debt Exchange Agreement, dated as of May 21, 2024, between Orgenesis Inc. and Yehuda Nir (Filed With SEC on May 23, 2024)

Debt Exchange Agreement, dated as of May 21, 2024, between Orgenesis Inc. and Aharon Lukach (Filed With SEC on May 23, 2024)

Debt Exchange Agreement, dated as of May 21, 2024, between Orgenesis Inc. and Yosef Dotan (Filed With SEC on May 23, 2024)

Asset Purchase and Strategic Collaboration Agreement, dated as of April 5, 2024, between Orgenesis Maryland LLC and Griffin Fund 3 BIDCO, Inc (Filed With SEC on April 11, 2024)

Form of March 2024 Warrant with $1.50 exercise price (Filed With SEC on March 7, 2024)

Form of March 2024 Warrant with $2.00 exercise price (Filed With SEC on March 7, 2024)

Securities Purchase Agreement, dated March 3, 2024, by and among the Company and the Investors (Filed With SEC on March 7, 2024)

Binding Term Sheet, dated as of February 26, 2024, between Orgenesis Maryland LLC and Germfree Laboratories LLC (Filed With SEC on March 1, 2024)

Unit Purchase Agreement, dated as of January 29, 2024, between the Company and MM OS Holdings L.P (Filed With SEC on January 31, 2024)

Term Sheet, dated as of January 18, 2024, between the Company and MM OS Holdings L.P (Filed With SEC on January 24, 2024)

Amendment Agreement, dated as of January 16, 2024, to Securities Purchase Agreement, dated November 8, 2023, by and among the Company and the November 2023 Investor (Filed With SEC on January 22, 2024)

Form of Nir Warrant, dated as of January 1, 2024 (Filed With SEC on January 5, 2024)

Form of Lukach Warrant, dated as of January 1, 2024 (Filed With SEC on January 5, 2024)

Loan Extension Agreement, dated as of January 1, 2024, by and between the Company and Yehuda Nir (Filed With SEC on January 5, 2024)

Loan Extension Agreement, dated as of January 1, 2024, by and between the Company and Aharon Lukach (Filed With SEC on January 5, 2024)

Employment Agreement between the Company and Victor Miller, dated December 28, 2023 (Filed With SEC on December 29, 2023)

Securities Purchase Agreement, dated August 31, 2023, by and among the Company and a certain investor (Filed With SEC on November 13, 2023)

Convertible Loan Agreement dated September 29, 2023, by and among the Borrower and Sai Traders (Filed With SEC on November 13, 2023)

Form of Placement Agent Agreement (Filed With SEC on November 8, 2023)

Form of Warrant (Filed With SEC on November 8, 2023)

Form of Securities Purchase Agreement, dated November 8, 2023, by and between Orgenesis Inc. and the Investor (Filed With SEC on November 8, 2023)

Convertible Loan Agreement dated September 29, 2023, by and among the Borrower and Sai Traders (Filed With SEC on October 5, 2023)

Securities Purchase Agreement, dated August 31, 2023, by and among the Company and the Investor (Filed With SEC on September 1, 2023)

Employment Agreement between the Company and Elliot Maltz, dated July 6, 2023 (Filed With SEC on July 12, 2023)

Amendment No. 2 to Unit Purchase Agreement dated as of May 5, 2023 by and among Orgenesis Inc., Morgenesis LLC and MM OS Holdings, L.P (Filed With SEC on July 7, 2023)

Amendment No. 1 to Second Amended and Restated Limited Liability Company Agreement of Morgenesis LLC (Filed With SEC on July 7, 2023)

Amendment No. 1 to Unit Purchase Agreement dated as of May 5, 2023 by and among Orgenesis Inc., Morgenesis LLC and MM OS Holdings, L.P (Filed With SEC on May 10, 2023)

Convertible Loan Agreement, dated March 27, 2023, by and among the Borrower and Yehuda Nir (Filed With SEC on March 31, 2023)

Form of Warrant (Filed With SEC on February 24, 2023)

Form of Securities Purchase Agreement between the Company and the Purchaser, dated February 23, 2023 (Filed With SEC on February 24, 2023)

Placement Agency Agreement between the Company and Joseph Gunnar & Co., LLC (Filed With SEC on February 24, 2023)

Convertible Credit Line and Unsecured Convertible Note Extension #2 Agreement, dated as of January 12, 2023, by and between the Company and Yosef Dotan (Filed With SEC on January 18, 2023)

Convertible Credit Line Extension Agreement, dated as of January 12, 2023, by and between the Company and Aharon Lukach (Filed With SEC on January 18, 2023)

Convertible Loans and Unsecured Convertible Notes Extension #2 Agreement, dated as of January 12, 2023, by and between the Company and Yehuda Nir (Filed With SEC on January 18, 2023)

Form of Warrant (Filed With SEC on January 13, 2023)

Convertible Loan Agreement, dated January 10, 2023, by and among the Company and NewTech Investment Holdings, LLC (Filed With SEC on January 13, 2023)

Convertible Loan Agreement, dated January 10, 2023, by and among the Company and Ariel Malik (Filed With SEC on January 13, 2023)

Unit Purchase Agreement dated as of November 4, 2022 by and among Orgenesis Inc., Morgenesis LLC and MM OS Holdings, L.P (Filed With SEC on November 7, 2022)

Form of Second Amended and Restated Limited Liability Company Agreement of Morgenesis LLC (Filed With SEC on November 7, 2022)

Services Agreement, dated as of November 4, 2022, by and between Morgenesis LLC and Orgenesis Inc (Filed With SEC on November 7, 2022)

Advisory Services and Monitoring Agreement dated as of November 4, 2022 by and between Morgenesis LLC and Metalmark Management II LLC (Filed With SEC on November 7, 2022)

Form of Nir Additional Warrant, dated as of October 23, 2022 (Filed With SEC on October 27, 2022)

Form of Neumann Additional Warrant, dated as of October 23, 2022 (Filed With SEC on October 27, 2022)

Convertible Loan Extension Agreement, dated as of October 23, 2022, by and between the Company and Yehuda Nir (Filed With SEC on October 27, 2022)

Convertible Loan Extension Agreement, dated as of October 23, 2022, by and between the Company and Ricky Neumann (Filed With SEC on October 27, 2022)

Amendment, Consent and Waiver Agreement, dated as of October 23, 2022, by and between the Company and Ricky Neumann (Filed With SEC on October 27, 2022)

Senior Secured Convertible Loan Agreement, dated August 15, 2022, by and among Morgenesis, Orgenesis, and the Lender (Filed With SEC on August 17, 2022)

Convertible Note Extension Agreement, dated July 15, 2022, by and among the Company and J. Ezra Merkin (Filed With SEC on July 20, 2022)

Form of Warrant (Filed With SEC on May 23, 2022)

Convertible Loan Agreement, dated May 19, 2022, by and among the Company and Ricky Neumann (Filed With SEC on May 23, 2022)

Form of Warrant (Filed With SEC on May 17, 2022)

Convertible Loan Agreement, dated May 17, 2022, by and among the Company and Southern Israel Bridging Fund Two, LP (Filed With SEC on May 17, 2022)

Amendment to Convertible Loan Agreement, dated May 16, 2022, by and among the Company and Yehuda Nir (Filed With SEC on May 16, 2022)

Form of Warrant (Filed With SEC on April 25, 2022)

Convertible Loan Agreement, dated April 21, 2022, by and among the Company and Yehuda Nir (Filed With SEC on April 25, 2022)

Form of Warrant (Filed With SEC on April 5, 2022)

Securities Purchase Agreement, dated March 30, 2022, by and among the Company and the Investors (Filed With SEC on April 5, 2022)

Registration Rights Agreement, dated March 30, 2022, by and among the Company and the Investors (Filed With SEC on April 5, 2022)

Employment Agreement, dated as of December 16, 2021, between the Company and Efrat Assa Kunik (Filed With SEC on March 30, 2022)

Form of Warrant, dated as of September 13, 2021, issued in connection with Convertible Note Extension Agreements (Filed With SEC on November 4, 2021)

Convertible Loan Agreement, dated as of August 24, 2021, between the Company and Image Securities FCZ (Filed With SEC on November 4, 2021)

Convertible Credit Line and Unsecured Convertible Note Extension Agreement, dated as of September 13, 2021, between the Company and Yosef Dotan (Filed With SEC on November 4, 2021)

Convertible Credit Line Extension Agreement, dated as of September 13, 2021, between the Company and Aharon Lukach (Filed With SEC on November 4, 2021)

Unsecured Convertible Note Extension Agreement, dated as of September 13, 2021, between the Company and Yehuda Nir (Filed With SEC on November 4, 2021)

Executive Directorship Agreement between the Company and Vered Caplan dated November 19, 2020 (Filed With SEC on March 9, 2021)

Swiss Employment Agreement between the Company and Vered Caplan dated November 19, 2020 (Filed With SEC on March 9, 2021)

Agreement and Plan of Merger and Reorganization, dated as of September 26, 2020 by and among Orgenesis Inc., Orgenesis Merger Sub, Inc., Koligo Therapeutics Inc., the Shareholders... (Filed With SEC on October 1, 2020)

Form of Registration Rights and Lock-Up Agreement between the Company, Long Hill Capital V, LLC and Maxim Group, LLC (Filed With SEC on October 1, 2020)

Form of Shareholders Lock-Up Agreement between the Company and Shareholders other than Long Hill Capital V, LLC (Filed With SEC on October 1, 2020)

Asset Purchase Agreement, dated April 12, 2020, by and between Orgenesis Inc., and Tamir Biotechnology, Inc (Filed With SEC on April 13, 2020)

Description of Securities (Filed With SEC on March 9, 2020)

Stock Purchase Agreement, dated February 2, 2020, by and among Orgenesis, Inc., GPP-II Masthercell LLC, Masthercell Global Inc. and Catalent Pharma Solutions, Inc. Disclosure... (Filed With SEC on February 3, 2020)

Form of Warrant (Filed With SEC on January 22, 2020)

Securities Purchase Agreement, dated January 20, 2020, by and among the Company and the Investors (Filed With SEC on January 22, 2020)

Registration Rights Agreement, dated January 20, 2020, by and among the Company and the Investors (Filed With SEC on January 22, 2020)

Form of Convertible Note convertible into Units,by and between the Company and Investors (Filed With SEC on November 7, 2019)

Form of Warrant included in Units, by and between the Company and Investors (Filed With SEC on November 7, 2019)

Convertible Loan Agreement, dated April 10, 2019, by and between the Company and Investor (Filed With SEC on November 7, 2019)

Form of Subscription Agreement, dated May 17, 2019, by and between the Company and Investor (Filed With SEC on November 7, 2019)

Form of Subscription Agreement, dated May 30, 2019, by and between the Company and Investor (Filed With SEC on November 7, 2019)

Form of Subscription Agreement, dated June 6, 2019, by and between the Company and Investor (Filed With SEC on November 7, 2019)

Transfer Agreement, dated as of August 7, 2019 by and among Masthercell Global, Orgenesis Inc. and GPP-II Masthercell, LLC (Filed With SEC on August 13, 2019)

Joint Venture Agreement between the Company and First Choice International Company, Inc. dated March 12, 2019 (Filed With SEC on May 8, 2019)

Convertible Loan Agreement between Orgenesis Maryland Inc. and Yosef Ram dated April 12, 2019 (Filed With SEC on May 8, 2019)

Joint Venture Agreement between the Company and KinerjaPay Corp. dated May 6, 2019 (Filed With SEC on May 8, 2019)

Controlled Equity OfferingSM Sales Agreement, dated December 20, 2018, by and between Orgenesis Inc. and Cantor Fitzgerald & Co (Filed With SEC on December 20, 2018)

Form of Convertible Note convertible into Units or Hemogenyx Securities (Filed With SEC on December 14, 2018)

Form of Convertible Note convertible into Units or Immungenyx Securities (Filed With SEC on December 14, 2018)

Form of Warrant included in Units (Filed With SEC on December 14, 2018)

Form of Subscription Agreement, dated December 10, 2018, by and between the Company and investor (Filed With SEC on December 14, 2018)

Form of Convertible Note convertible into Units or Hemogenyx Securities (Filed With SEC on December 6, 2018)

Form of Convertible Note convertible into Units or Immungenyx Securities (Filed With SEC on December 6, 2018)

Form of Warrant included in Units (Filed With SEC on December 6, 2018)

Form of Subscription Agreement, dated November 30, 2018, by and between the Company and investor (Filed With SEC on December 6, 2018)

Form of Convertible Note convertible into Units or Hemogenyx Securities (Filed With SEC on November 28, 2018)

Form of Convertible Note convertible into Units or Immugenyx Securities (Filed With SEC on November 28, 2018)

Form of Warrant included in Units (Filed With SEC on November 28, 2018)

Form of Subscription Agreement, dated November 21, 2018, by and between the Company and investor (Filed With SEC on November 28, 2018)

Form of Convertible Note convertible into Units or Hemogenyx Securities (Filed With SEC on November 20, 2018)

Form of Convertible Note convertible into Units or Immungenyx Securities (Filed With SEC on November 20, 2018)

Form of Warrant included in Units (Filed With SEC on November 20, 2018)

Subscription Agreement, dated November 13, 2018, by and between the Company and Avner Sonnino (Filed With SEC on November 20, 2018)

Collaboration and License Agreement, dated as of June 18, 2018, between Orgenesis Inc. and Mircod Limited (Filed With SEC on October 12, 2018)

Collaboration and License Agreement, dated as of June 19, 2018, between Orgenesis Inc. and Mircod Limited (Filed With SEC on July 17, 2018)

Advisory Services Agreement dated as of June 27, 2018 between Masthercell Global Inc. and Great Point Partners LLC (Filed With SEC on June 29, 2018)

Stock Purchase Agreement dated as of June 27, 2018 by and among Orgenesis Inc., Masthercell Global Inc. and GPP-II Masthercell, LLC (Filed With SEC on June 29, 2018)

Masthercell Global Inc. Stockholders Agreement dated as of June 27, 2018 by and among Masthercell Global Inc., GPP-II Masthercell LLC and Orgenesis Inc (Filed With SEC on June 29, 2018)

Contribution Assignment and Assumption Agreement dated as of June 27, 2018 by and among Masthercell Global Inc. and Orgenesis Inc (Filed With SEC on June 29, 2018)

Technology Transfer Agreement dated as of June 27, 2018 between Orgenesis Inc. and Masthercell Global Inc (Filed With SEC on June 29, 2018)

Amended and Restated Certificate of Incorporation of Masthercell Global Inc. dated as of June 27, 2018 to be filed with the Secretary of State of the State of Delaware (Filed With SEC on June 29, 2018)

Executive Employment Agreement dated as of March 30, 2017 between Orgensis Inc. and Vered Caplan (Filed With SEC on July 24, 2017)

Amendment No. 1 dated May 10, 2017 to Executive Employment Agreement dated as of March 30, 2017 between Orgensis Inc. and Vered Caplan (Filed With SEC on July 24, 2017)

Joint Venture Agreement dated as of May 10, 2016 between Orgenesis Inc. and Atvio Biotech Ltd (Filed With SEC on April 19, 2017)

Private Placement Subscription Agreement dated January 26, 2017 between Orgenesis Inc. and Image Securities FZC (Filed With SEC on April 19, 2017)

Amendment No. 1 dated February 9, 2017 to the Private Placement Subscription Agreement between Orgenesis Inc. and Image Securities FZC (Filed With SEC on April 19, 2017)

Joint Venture Agreement (Filed With SEC on February 28, 2017)

Release Agreement, dated as of November 18, 2016 among Orgenesis Maryland Inc., Scott Carmer and Orgenesis Inc (Filed With SEC on November 23, 2016)

Strategic Advisory Agreement dated as of November 18, 2016 between Orgenesis Inc. and Scott Carmer (Filed With SEC on November 23, 2016)

Loan Agreement dated as of September 28, 2016 between the FPIM and MaSTherCell (Filed With SEC on October 14, 2016)

Form of Subscription Agreement (Filed With SEC on April 14, 2016)

Form of Securities Purchase Agreement and Note Payable Credit Line Agreement (Filed With SEC on April 14, 2016)

Amendment No. 2 to Share Exchange Agreement (Filed With SEC on November 13, 2015)

March 23, 2015 Memorandum of Understanding with Global Stem Cell & Regenerative Medicine Acceleration Center (Filed With SEC on April 9, 2015)

March 25, 2015 Memorandum of Understanding with CureCell Co., Ltd (Filed With SEC on April 9, 2015)

Orgenesis Inc. Board of Advisors Consulting Agreement dated March 16, 2015 (Filed With SEC on March 17, 2015)

Addendum 1 to Share Exchange Agreement dated March 2, 2015 with MaSTherCell SA, Cell Therapy Holding SA and their shareholders (Filed With SEC on March 5, 2015)

Escrow Agreement dated February 27, 2015 with the shareholders of MasTHerCell SA and Cell Therapy Holding SA and bondholders of MaSTherCell SA and Securities Transfer Corporation (Filed With SEC on March 5, 2015)

Share Exchange Agreement dated November 3, 2014 with MasTHerCell SA and Cell Therapy Holding SA (Filed With SEC on November 10, 2014)

Personal Employment Agreement, by and between Orgenesis Ltd. and Vered Caplan, dated August 22, 2014 (Filed With SEC on August 25, 2014)

Employment Agreement dated July 23, 2014 between Orgenesis Maryland Inc. and Scott Carmer (Filed With SEC on August 7, 2014)

Consulting Agreement dated August 1, 2014 with Eventus Consulting, P.C (Filed With SEC on August 5, 2014)

Employment Agreement dated August 1, 2014 with Neil Reithinger (Filed With SEC on August 5, 2014)

Services Agreement between Orgenesis SPRL and MaSTherCell SA dated July 3, 2014 (Filed With SEC on July 7, 2014)

Convertible Loan Agreement dated May 29, 2014 with Nine Investments Limited (Filed With SEC on May 30, 2014)

form of subscription agreement with form of warrant (Filed With SEC on April 28, 2014)

Personal Employment Agreement dated April 16, 2014 by and between Orgenesis Ltd. and Joseph Tenne (Filed With SEC on April 16, 2014)

Consulting Agreement dated April 3, 2014 with Aspen Agency Limited (Filed With SEC on April 7, 2014)

Stock Option Agreement dated April 3, 2014 with Aspen Agency Limited (Filed With SEC on April 7, 2014)

form of subscription agreement (Filed With SEC on March 4, 2014)

form of warrant (Filed With SEC on March 4, 2014)

Term sheet with Mediapark Investments Limited (Filed With SEC on December 17, 2013)

Convertible Loan Agreement dated December 6, 2013 with Mediapark Investments Limited (Filed With SEC on December 17, 2013)

Investment Agreement dated December 13, 2013 with Kodiak Capital Group, LLC (Filed With SEC on December 17, 2013)

Registration Rights Agreement dated December 13, 2013 with Kodiak Capital Group, LLC (Filed With SEC on December 17, 2013)

Employment Agreement with Sav DiPasquale dated February 17, 2013 (Filed With SEC on October 25, 2013)

Letter Agreement with Sav DiPasquale dated May 29, 2013 (Filed With SEC on October 25, 2013)

May 6, 2013 Process Development Agreement with ATI BVBA (Filed With SEC on May 9, 2013)

Form of subscription agreement (Filed With SEC on May 9, 2013)

Form of warrant (Filed With SEC on May 9, 2013)

Registration Rights Agreement (Filed With SEC on May 9, 2013)

Board of Advisors Consulting Agreement dated April ________, 2013 (Filed With SEC on April 9, 2013)

form of subscription and loan agreement (Filed With SEC on March 26, 2013)

form of warrant (Filed With SEC on March 26, 2013)

Employment Term Sheet dated December 17, 2012 (Filed With SEC on January 7, 2013)

Cancellation and Amendment of Warrants Agreement (Filed With SEC on December 10, 2012)

Board of Advisors Consulting Agreement dated November 14, 2012 (Filed With SEC on November 27, 2012)

Service Agreement with Fraunhofer Institute for Interfacial Engineering and Biotechnology (Filed With SEC on November 9, 2012)

Termination Letter to Investor Relations Group Inc. dated October 5, 2012 (Filed With SEC on October 9, 2012)

Form of subscription agreement (Filed With SEC on August 3, 2012)

Form of warrant certificate (Filed With SEC on August 3, 2012)

Board of Advisors Consulting Agreement April 14, 2012 (Filed With SEC on May 31, 2012)

Letter Agreement with the Investor Relations Group Inc. dated May 2, 2012 (Filed With SEC on May 31, 2012)

Form of subscription agreement (Filed With SEC on May 2, 2012)

Form of warrant certificate (Filed With SEC on May 2, 2012)

Director Agreement with Etti Hanochi dated April 6, 2012 (Filed With SEC on April 25, 2012)

Director Agreement with Yaron Adler dated April 6, 2012 (Filed With SEC on April 23, 2012)

Research Services Agreement with Tel Hashomer - Medical Research, Infrastructure and Services Ltd. dated March 22, 2012 (Filed With SEC on April 13, 2012)

Category

Industry

Companies

Contracts

Orgenesis Inc. Contracts & Agreements